NEW YORK – Quest Diagnostics said late Monday that it is offering $750 million in aggregated principal amount senior notes.
The firm said the notes are due in 2033 with an interest rate of 6.4 percent. The offering is expected to close on Nov. 1, subject to customary closing conditions.
Quest intends to use the proceeds for general corporate purposes, which could include redeeming or repaying the firm's $300 million of 4.25 percent senior notes that are due in 2024 as well as outstanding debts incurred under the company's senior unsecured revolving facility and secured receivables credit facility.
The bookrunning managers for the offering are Goldman Sachs, Mizuho Securities, and Morgan Stanley.